Precision Nutrition Takes Center Stage in New Ketogenic Therapy Trial and Service

$3.3 million gift from Baszucki Group fuels transformative bipolar disorder research and precision nutrition clinical service.

Baszucki Group announces a collaboration with Mayo Clinic to support a clinical trial investigating ketogenic therapy for bipolar disorder. This important study will further explore the intersection of metabolic and mental health along with cardio-metabolic implications, with the goal of informing the development of an interdisciplinary precision nutrition clinical service.

New Bipolar Disorder Study Shows that a Ketogenic Diet Leads to Mental and Physical Health Benefits

“For the first time in years, I felt like my brain was finally running on the right fuel,” said one of the participants in a new pilot study on a ketogenic diet in bipolar disorder. Published today in BJPsych Open, the study is the first to use neuroimaging to demonstrate that a ketogenic diet may improve brain metabolism in individuals with a bipolar disorder diagnosis.

Researchers explore ketogenic diet’s effects on bipolar disorder among teenagers, young adults

UCLA Health is set to begin a multi-site pilot study to explore whether a ketogenic diet, when combined with mood stabilizing medications, helps stabilize mood symptoms in teenagers and young adults who have bipolar disorder.

Metabolic Psychiatry Scholar Award

Today Baszucki Group announces and invites proposals for the Metabolic Psychiatry Scholar Award, a new funding opportunity designed to support and elevate outstanding early-career investigators bridging the fields of metabolism and mental health.